Peter Goldman
Impact in
-
- Complementary and Alternative Medicine Studies
- Acupuncture Treatment Research Studies
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Gut microbiota and health 13
- Enzyme function and inhibition 11
- Enzyme Catalysis and Immobilization 6
- Physiology 19
- Diet and metabolism studies 8
- Co-authors
- Mark A. Peppercorn (8 shared papers)P. Roy Vagelos (6 shared papers)Laura C. Green (1 shared paper)Steven R. Tannenbaum (1 shared paper)Ted J. Kaptchuk (4 shared papers)Ronald L. Koch (10 shared papers)Catherine L. Drennan (7 shared papers)Carl C. Levy (5 shared papers)
- Journals
- Biochemical Pharmacology (20 papers)Journal of Biological Chemistry (14 papers)Proceedings of the National Academy of Sciences (7 papers)New England Journal of Medicine (7 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)
- Partner nations
- United StatesUnited KingdomMalaysia
In The Last Decade
Peter Goldman
126 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Complementary and alternative medicine 791
- Pharmacology 517
- Biochemistry 418
- Pharmaceutical Science 311
- Cognitive Neuroscience 760
Countries citing papers authored by Peter Goldman
This map shows the geographic impact of Peter Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Goldman more than expected).
Fields of papers citing papers by Peter Goldman
This network shows the impact of papers produced by Peter Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Goldman. The network helps show where Peter Goldman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Goldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome Hit paper breakdown → | 2008 | 833 |
| 2 | Nitrate Synthesis in the Germfree and Conventional Rat Hit paper breakdown → | 1981 | 440 |
| 3 | THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE Hit paper breakdown → | 1972 | 357 |
| 4 | 2000 | 344 | |
| 5 | 1961 | 311 | |
| 6 | 1973 | 209 | |
| 7 | 2001 | 148 | |
| 8 | 1965 | 147 | |
| 9 | 2004 | 134 | |
| 10 | 2014 | 133 | |
| 11 | 1969 | 125 | |
| 12 | 1976 | 107 | |
| 13 | 2013 | 103 | |
| 14 | 1968 | 102 | |
| 15 | 1967 | 93 | |
| 16 | 2016 | 88 | |
| 17 | 1980 | 87 | |
| 18 | 1979 | 87 | |
| 19 | 1971 | 85 | |
| 20 | 1963 | 83 |
About Peter Goldman
Peter Goldman is a scholar working on Molecular Biology, Physiology, Infectious Diseases, Pharmaceutical Science and Food Science, having authored 127 papers that have together received 6.5k indexed citations. Recurring topics across this work include Gut microbiota and health (13 papers), Enzyme function and inhibition (11 papers), Clostridium difficile and Clostridium perfringens research (8 papers), Diet and metabolism studies (8 papers), Metabolism and Genetic Disorders (8 papers), Probiotics and Fermented Foods (8 papers), Enzyme Catalysis and Immobilization (6 papers) and Muscle metabolism and nutrition (6 papers). The work is most often cited by research in Complementary and alternative medicine (791 citations), Pharmacology (517 citations), Biochemistry (418 citations), Pharmaceutical Science (311 citations) and Cognitive Neuroscience (760 citations). Peter Goldman has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Mark A. Peppercorn, P. Roy Vagelos, Laura C. Green, Steven R. Tannenbaum, Ted J. Kaptchuk, Ronald L. Koch, Catherine L. Drennan, Carl C. Levy, William B. Stason and David A. Stone. Their work appears in journals such as Biochemical Pharmacology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, New England Journal of Medicine and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.